Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 15, 2010

View Archived Issues

Pritumumab is active in patients with brain cancer

GlycoVaxyn reports phase I data on Shigella dysenteriae vaccine

IPI-926 is well tolerated and active in patients with solid tumors

GAA peptide-loaded DC1-based vaccine shows promise in recurrent malignant glioma

French scientists claim new inhibitors of cell division protein kinases

Prosidion describes new GPR119 receptor agonists

Continuous exenatide delivery with ITCA-650 shows promise in phase II diabetes trial

Preclinical and phase I data presented on Algipharma's OligoG

Takeda and Envoy Therapeutics collaborate on schizophrenia research

UCB and Synosia Therapeutics enter into strategic neurology alliance

Novartis renews agreement with WHO to provide free leprosy drugs

Bazedoxifene launched in Japan and Spain for postmenopausal osteoporosis

Almirall presents pharmacological profile of LAS-189913, a new candidate therapeutic for MS

Bristol-Myers Squibb acquires ZymoGenetics

First patient with spinal cord injury is treated in phase I trial of GRNOPC1

FDA funds phase I trial of genetically reprogrammed HSV in childhood cancer

Phase II trial studies sildenafil for heart failure in Duchenne's muscular dystrophy

Pfizer to acquire King Pharmaceuticals and expand pain product portfolio

FDA warns of increased risk of thigh bone fracture with bisphosphonates use

Merck & Co. claims new diacylglycerol O-acyltransferase 1 inhibitors

Olatec Industries patents agents with anti-inflammatory and analgesic potential

New deuterated alpha-(N-sulfonamido)acetamide beta-APP42 production inhibitors claimed

ERYtech and Genzyme to conduct feasibility studies with new therapeutic enzyme formulation

Shire acquires 99.21% of Movetis shares, proceeding with squeeze-out of remaining shares

Twice-daily tramadol/acetaminophen approved in eight European countries

Innate Therapeutics begins phase II trial of MIS-416 in progressive MS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...